Enjoy complimentary customisation on priority with our Enterprise License!
The cardiovascular catheters market size is forecast to increase by USD 7.6 billion at a CAGR of 8.13% between 2024 and 2028.
The global cardiovascular catheters market is witnessing significant growth due to the rising incidence of cardiac diseases and the expansion of insurance coverage for cardiovascular procedures. This trend is expected to continue as the aging population and sedentary lifestyles contribute to an increased prevalence of cardiovascular conditions. Additionally, advancements in technology are leading to the development of minimally invasive and cost-effective catheter-based procedures, making them increasingly popular among healthcare providers and patients. However, the high cost of these procedures remains a challenge for many patients and payers, limiting access to care in some regions. To address this issue, market players are exploring strategies such as partnerships with insurance providers and the development of affordable alternatives. Overall, the cardiovascular catheters market is poised for robust growth, driven by these key trends and challenges.
The market is expected to experience significant growth due to the increasing prevalence of cardiovascular diseases (CVDs), including coronary heart disease and stroke. According to the World Health Organization, CVDs are the leading cause of death globally, accounting for approximately 17.9 million deaths each year. The market is driven by the need for early diagnosis and treatment of medical conditions related to the cardiovascular system, urology, gastrointestinal tract, and nervous system. Cardiovascular catheters are used in various medical procedures such as coronary angiography, angioplasty, and 3D mapping for the diagnosis and treatment of cardiovascular disorders. Urinary catheters are used for the treatment of chronic illnesses like bladder problems. Various governments and organizations are focusing on public health initiatives to increase awareness and early detection of chronic diseases, further driving market growth. Advancements in technology, including remote monitoring, nanotechnology, and 3D mapping, are expected to provide new opportunities for market growth. Physicians and patients alike benefit from these advancements, leading to increased demand for cardiovascular catheter systems. The market is expected to grow steadily over the forecast period, providing significant opportunities for market participants.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion " for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The Cardiovascular therapeutic catheters segment is estimated to witness significant growth during the forecast period. The Cardiovascular Catheters Market encompasses a range of medical devices used in diagnosing and treating cardiovascular diseases (CVDs) and chronic disorders, including congenital heart disease, arrhythmia, and blocked arteries. Cardiovascular catheterization procedures, such as Coronary angiography for Coronary Heart Disease, are essential for evaluating the cardiovascular system, leading to the growth of the market. Cardiovascular catheters include conventional catheters, DEB (Drug-Eluting Balloon) catheters, cutting balloon catheters, scoring balloon catheters, and cardiac ablation catheters. Conventional catheters are traditional balloon catheters used for angiography purposes and are more affordable than DEB catheters. DEB catheters, with their antiproliferative drug-coated surfaces, are increasingly popular for peripheral artery disease treatment. Cutting balloon catheters are used for dilation of stenosis in coronary arteries, while scoring balloon catheters are employed for restenosis and complex lesions. Cardiac ablation catheters are essential for ablation procedures, which treat abnormal heart rhythms.
Advancements in medical manufacturing technologies, such as 3D mapping, have led to the development of additional features in catheter systems. These improvements include double-lumen catheters and intravenous catheters, which facilitate the administration of medications and bodily fluids during medical procedures. Affordability, insurance coverage, and hospitalizations are crucial factors influencing the healthcare providers' and healthcare professionals' decisions regarding catheter selection. The global cardiovascular catheters market is expected to grow significantly due to the increasing prevalence of cardiovascular diseases and chronic illnesses, as well as the rising healthcare spending. Gastrointestinal catheters, such as those used in the Gastrointestinal tract, are also part of the cardiovascular catheters market. These catheters are essential for diagnosing and treating medical conditions related to the Gastrointestinal tract. Overall, the cardiovascular catheters market plays a vital role in the cardiovascular devices industry, improving patient outcomes and enhancing the quality of medical procedures.
Get a glance at the market share of various segments Request Free Sample
The Cardiovascular therapeutic catheters segment accounted for USD 7.90 billion in 2018 - 2022 and showed a gradual increase during the forecast period.
The global cardiovascular catheters market is witnessing significant growth due to the increasing prevalence of myocardial infarction and other cardiovascular diseases. The mortality rate associated with these conditions is high, making early diagnosis and intervention crucial. Advanced technologies such as nanotechnology are being integrated into cardiovascular catheters to enhance their diagnostic capabilities. Nervous system disorders and ophthalmic ailments are also driving the demand for specialized catheters, including single-lumen and triple-lumen catheters. Patient education and remote monitoring are essential components of effective treatment strategies. Physicians require specialized skills to perform surgical procedures, including urology catheters for urinary tract-related diseases and urological conditions like urinary retention. Reimbursement policies and scenarios play a vital role in determining the affordability of these procedures. Sedentary lifestyles and an aging population are contributing factors to the increasing prevalence of vascular catheters for valvular disease and other conditions. Skilled surgeons and comprehensive training programs are essential to ensure the quality of surgical procedures. In addition, therapeutic purposes of cardiovascular catheters, such as delivering medications directly to the affected area, are gaining popularity. Remote monitoring technologies enable continuous patient care and improve overall patient outcomes.
For more insights on the market share of various regions Request Free Sample
Asia is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The prevalence of cardiac diseases is on the rise, and an increasing number of insurance providers are offering coverage for related treatments. The global market for cardiovascular devices, specifically those used in the treatment of cardiovascular diseases (CVDs) and cardiac disorders, is experiencing significant growth due to the increasing prevalence of these conditions. According to the National Institutes of Health (NIH), approximately 10% of the global population aged 75 years and above are affected by degenerative abnormalities related to severe aortic stenosis, mitral and tricuspid regurgitation, and other cardiac diseases. With an aging population base in both developed and developing countries, the incidence of CVDs is expected to rise, leading to increased demand for cardiovascular devices. Advancements in medical manufacturing technologies have resulted in the development of innovative cardiovascular catheters with additional features such as 3D mapping and double-lumen designs. These catheters are used in medical procedures like Angioplasty and Coronary angiography for treating blocked arteries and arrhythmias. The affordability of these catheter systems, coupled with insurance coverage and hospitalizations, is making these treatments more accessible to patients with chronic illnesses like coronary heart disease and congenital heart disease. Gastrointestinal catheters, intravenous catheters, and catheter systems are also in demand for the treatment of medical diseases and disorders in the Gastrointestinal tract. Biomerics, a leading manufacturer of medical equipment, offers a range of catheters with advanced technologies for healthcare providers to deliver medications and monitor bodily fluids effectively. The affordability and accessibility of these catheters are crucial in reducing healthcare spending on hospitalizations and improving patient outcomes.
Business strategies will surface in the market, reflecting the innovative approaches and adaptability of organizations to meet consumer demands and market trends. The Cardiovascular Catheters Market encompasses various types of catheters used in diagnosing and treating cardiovascular diseases (CVDs) and disorders, including congenital heart disease, arrhythmia, and blocked arteries. Cardiovascular catheterization procedures, such as Angioplasty and Coronary angiography, are essential for the diagnosis and treatment of these conditions. Cardiovascular devices industry continues to evolve with advancements in medical manufacturing technologies, leading to the development of innovative catheter systems with additional features, such as 3D mapping and double-lumen catheters. Stryker, a leading medical equipment manufacturer, offers reprocessed single-use cardiovascular catheters through its department, Stryker Sustainability Solutions. Despite concerns regarding medical safety, these catheters undergo rigorous processing and sterilization procedures, ensuring infection reduction. Reprocessing of single-use catheters offers affordability, benefiting both patients and healthcare providers, reducing healthcare spending and hospitalizations. Stryker Sustainability Solutions provides introducer sheaths, such as Agilis NxT, used in Electrophysiology (EP) procedures, manufactured by St. Jude Medical. The affordability of reprocessed cardiovascular catheters is crucial, especially for chronic illnesses and chronic disorders, where patients require frequent procedures and long-term medication. Intravenous catheters and catheter systems are also essential in the gastrointestinal tract for managing bodily fluids and administering medications. Healthcare professionals and providers continue to rely on these medical devices to improve patient outcomes and reduce healthcare spending. Insurance coverage plays a significant role in the accessibility of these procedures and devices, making affordability a crucial factor in the Cardiovascular Catheters Market.
The expense of undergoing cardiovascular procedures can be significant. These medical interventions, essential for maintaining cardiovascular health, come with a considerable financial burden. The Cardiovascular Catheters Market encompasses a range of medical devices used in the diagnosis and treatment of cardiovascular diseases (CVDs) and chronic disorders, including arrhythmia, congenital heart disease, and blocked arteries. Cardiac catheterization, a common medical procedure, utilizes catheter systems for Coronary Angiography and Angioplasty. Angioplasty involves the use of balloon catheters, stents, and embolic protection devices to widen blocked arteries. The high cost of these procedures, with PCI procedures ranging from USD12,000 to USD38,000, restricts access for many patients due to limited insurance coverage and affordability concerns. Innovations such as 3D mapping and additional features in catheters are being introduced to enhance the accuracy and effectiveness of medical procedures. Biometrics , a leading player in the Cardiovascular Devices industry, manufactures a range of catheters, including double-lumen catheters for Coronary Heart Disease and Gastrointestinal tract procedures. Medical Manufacturing Technologies continue to advance, leading to the development of intravenous catheters and catheter systems for various medical procedures. Healthcare professionals and providers aim to improve patient outcomes while reducing hospitalizations and healthcare spending. The use of catheters in the treatment of cardiovascular diseases and chronic illnesses is a critical aspect of modern medical care. Bodily fluids are carefully monitored during these procedures to ensure patient safety. Medications are administered intravenously through catheters to manage symptoms and promote healing. The affordability and accessibility of these essential medical devices remain crucial considerations for patients and healthcare systems alike.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbott Laboratories - As a leading provider in the cardiovascular catheters market, our company offers a comprehensive range of specialized catheters for various applications. These include coronary dilatation catheters, designed for the treatment of coronary artery diseases, and peripheral dilatation catheters, utilized for the treatment of peripheral vascular diseases. In addition, we provide diagnostic catheters, which are essential tools for accurately assessing cardiovascular conditions through various imaging techniques. Our commitment to innovation and quality ensures that our cardiovascular catheters meet the highest industry standards, enabling healthcare professionals to deliver optimal patient care.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The global cardiovascular catheters market is expected to experience significant growth due to the increasing prevalence of cardiovascular diseases (CVDs) and cardiovascular disorders. These conditions include coronary heart disease, arrhythmia, congenital heart disease, and blocked arteries. Cardiovascular catheters are essential medical devices used in cardiac catheterization procedures, such as angioplasty and coronary angiography. Advancements in medical manufacturing technologies, including 3D mapping and additional features, are enhancing the functionality of cardiovascular catheters. The affordability of these catheters is also driving market growth, making them accessible to a larger patient population. The cardiovascular devices industry is witnessing an increase in healthcare spending, hospitalizations, and insurance coverage for CVD treatments. The use of catheters in medical procedures for treating chronic diseases and disorders, such as chronic illnesses and gastrointestinal diseases, is also expanding the market. Catheter systems, including double-lumen and intravenous catheters, are used in various medical procedures, from cardiac catheterization to monitoring bodily fluids. Brands like Biomerics are leading the market with innovative catheter designs and materials. The market is expected to continue growing, driven by the increasing demand for minimally invasive procedures and the need for effective treatments for CVDs.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
174 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 8.13% |
|
Market growth 2024-2028 |
USD 7.6 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
7.55 |
|
Regional analysis |
Asia, North America, Europe, and Rest of World (ROW) |
|
Performing market contribution |
Asia at 37% |
|
Key countries |
India, China, Germany, UK, and US |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Abbott Laboratories, B.Braun SE, Becton Dickinson and Co., BIOTRONIK SE and Co. KG, Boston Scientific Corp., Cardinal Health Inc., CardioFocus Inc., Cardionovum GmbH, CathRx Pty Ltd., Cook Group Inc., Edwards Lifesciences Corp., Getinge AB, Innovative Cardiovascular Solutions LLC, Johnson and Johnson Services Inc., LivaNova PLC, Medtronic Plc, Merit Medical Systems Inc., MicroPort Scientific Corp., Terumo Corp., and ZOLL Medical Corp. |
|
Market dynamics |
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.